ZA977327B - Pharmaceutical composition containing 4-oxobutanoic acids. - Google Patents
Pharmaceutical composition containing 4-oxobutanoic acids.Info
- Publication number
- ZA977327B ZA977327B ZA9707327A ZA977327A ZA977327B ZA 977327 B ZA977327 B ZA 977327B ZA 9707327 A ZA9707327 A ZA 9707327A ZA 977327 A ZA977327 A ZA 977327A ZA 977327 B ZA977327 B ZA 977327B
- Authority
- ZA
- South Africa
- Prior art keywords
- pharmaceutical composition
- composition containing
- oxobutanoic acids
- oxobutanoic
- acids
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/60—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/76—Unsaturated compounds containing keto groups
- C07C59/84—Unsaturated compounds containing keto groups containing six membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
- C07C69/738—Esters of keto-carboxylic acids or aldehydo-carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/16—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Furan Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9610254A FR2752422B1 (fr) | 1996-08-16 | 1996-08-16 | Composition pharmaceutique contenant des acides 4-oxo-butanoiques |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA977327B true ZA977327B (en) | 1998-03-30 |
Family
ID=9495089
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA9707327A ZA977327B (en) | 1996-08-16 | 1997-08-14 | Pharmaceutical composition containing 4-oxobutanoic acids. |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US6143787A (ru) |
| EP (1) | EP0925273B1 (ru) |
| JP (1) | JP3105545B2 (ru) |
| KR (1) | KR100488430B1 (ru) |
| CN (1) | CN1082370C (ru) |
| AR (1) | AR009251A1 (ru) |
| AT (1) | ATE208364T1 (ru) |
| AU (1) | AU725440B2 (ru) |
| BR (1) | BR9711315A (ru) |
| CA (1) | CA2263348C (ru) |
| CY (1) | CY2298B1 (ru) |
| CZ (1) | CZ294165B6 (ru) |
| DE (1) | DE69708130T2 (ru) |
| DK (1) | DK0925273T3 (ru) |
| ES (1) | ES2166098T3 (ru) |
| FR (1) | FR2752422B1 (ru) |
| HK (1) | HK1021728A1 (ru) |
| HU (1) | HUP0004223A3 (ru) |
| ID (1) | ID17875A (ru) |
| NO (1) | NO312290B1 (ru) |
| PL (1) | PL187371B1 (ru) |
| PT (1) | PT925273E (ru) |
| RU (1) | RU2175966C2 (ru) |
| SI (1) | SI0925273T1 (ru) |
| SK (1) | SK283055B6 (ru) |
| TR (1) | TR199900329T2 (ru) |
| TW (1) | TW438764B (ru) |
| UA (1) | UA57031C2 (ru) |
| WO (1) | WO1998007681A1 (ru) |
| ZA (1) | ZA977327B (ru) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH04318852A (ja) * | 1991-04-18 | 1992-11-10 | Fujitsu Ltd | レジスト・パターン形成方法 |
| NZ530051A (en) | 2001-06-12 | 2006-12-22 | Wellstat Therapeutics Corp | Polycyclic oxy-aromatic acid derivatives for the treatment of metabolic disorders |
| FR2832633B1 (fr) * | 2001-11-28 | 2004-09-24 | Lipha | Composition pharmaceutique comprenant une association metformine et un acide 4-oxo-butanoique et son utilisation pour traiter le diabete |
| FR2832925B1 (fr) * | 2001-12-03 | 2006-07-14 | Lipha | Utilisation de derives de l'acide 4-oxobutanoique dans le traitement de l'inflammation |
| FR2834214B1 (fr) * | 2001-12-28 | 2004-09-24 | Lipha | Composition pharmaceutique comprenant un inhibiteur d'alpha-glucosidase et un acide 4-oxo-butanoique et son utilisation pour traiter le diabete |
| FR2834640B1 (fr) * | 2002-01-11 | 2004-09-24 | Lipha | Composition pharmaceutique comprenant une glitazone et un acide 4-oxobutanoique et son utilisation pour traiter le diabete |
| EP1556085A4 (en) * | 2002-11-01 | 2012-08-22 | Wellstat Therapeutics Corp | COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS |
| WO2004041256A2 (en) * | 2002-11-08 | 2004-05-21 | Novo Nordisk A/S | Safe chemical uncouplers for the treatment of obesity |
| FR2849598B1 (fr) * | 2003-01-07 | 2006-09-22 | Merck Sante Sas | Utilisation d'inhibiteurs de la kynurenine-3-hydroxylase pour le traitement du diabete, par augmentation du nombre de cellules des ilots de langerhans |
| FR2849599B1 (fr) * | 2003-01-07 | 2006-12-29 | Merck Sante Sas | Utilisation d'inhibiteurs de la kynurenine-3-hydroxylase pour le traitement du diabete |
| PT1633340E (pt) * | 2003-04-15 | 2011-02-22 | Wellstat Therapeutics Corp | Compostos para o tratamento de distúrbios metabólicos |
| US20100273872A1 (en) | 2007-12-03 | 2010-10-28 | Valerie Autier | Use of 4-oxobutanoic acid derivatives in the treatment of pathologies associated with immunological disorders |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5250517A (en) * | 1987-10-06 | 1993-10-05 | Hoffmann-La Roche Inc. | Renin inhibiting compounds |
| DK523288A (da) * | 1987-10-06 | 1989-04-07 | Hoffmann La Roche | Aminosyrederivater |
| CA1329680C (en) * | 1987-11-23 | 1994-05-17 | Harold Norris Weller, Iii | N-heterocyclic alcohol derivatives |
| US5055466A (en) * | 1987-11-23 | 1991-10-08 | E. R. Squibb & Sons, Inc. | N-morpholino derivatives and their use as anti-hypertensive agents |
-
1996
- 1996-08-16 FR FR9610254A patent/FR2752422B1/fr not_active Expired - Fee Related
-
1997
- 1997-05-08 UA UA99031301A patent/UA57031C2/ru unknown
- 1997-08-05 DE DE69708130T patent/DE69708130T2/de not_active Expired - Lifetime
- 1997-08-05 DK DK97936682T patent/DK0925273T3/da active
- 1997-08-05 JP JP10510330A patent/JP3105545B2/ja not_active Expired - Fee Related
- 1997-08-05 RU RU99105208/04A patent/RU2175966C2/ru not_active IP Right Cessation
- 1997-08-05 SK SK180-99A patent/SK283055B6/sk not_active IP Right Cessation
- 1997-08-05 KR KR10-1999-7001122A patent/KR100488430B1/ko not_active IP Right Cessation
- 1997-08-05 CZ CZ1999498A patent/CZ294165B6/cs not_active IP Right Cessation
- 1997-08-05 PT PT97936682T patent/PT925273E/pt unknown
- 1997-08-05 HU HU0004223A patent/HUP0004223A3/hu unknown
- 1997-08-05 EP EP97936682A patent/EP0925273B1/fr not_active Expired - Lifetime
- 1997-08-05 BR BR9711315A patent/BR9711315A/pt not_active IP Right Cessation
- 1997-08-05 US US09/230,849 patent/US6143787A/en not_active Expired - Fee Related
- 1997-08-05 AT AT97936682T patent/ATE208364T1/de not_active IP Right Cessation
- 1997-08-05 AU AU39422/97A patent/AU725440B2/en not_active Ceased
- 1997-08-05 CA CA002263348A patent/CA2263348C/en not_active Expired - Fee Related
- 1997-08-05 TR TR1999/00329T patent/TR199900329T2/xx unknown
- 1997-08-05 SI SI9730237T patent/SI0925273T1/xx unknown
- 1997-08-05 WO PCT/EP1997/004252 patent/WO1998007681A1/fr active IP Right Grant
- 1997-08-05 ES ES97936682T patent/ES2166098T3/es not_active Expired - Lifetime
- 1997-08-05 CN CN97197180A patent/CN1082370C/zh not_active Expired - Fee Related
- 1997-08-14 ID IDP972848A patent/ID17875A/id unknown
- 1997-08-14 ZA ZA9707327A patent/ZA977327B/xx unknown
- 1997-08-15 AR ARP970103720A patent/AR009251A1/es active IP Right Grant
- 1997-10-23 TW TW086115700A patent/TW438764B/zh active
-
1999
- 1999-02-12 PL PL97331645A patent/PL187371B1/pl not_active IP Right Cessation
- 1999-02-15 NO NO19990707A patent/NO312290B1/no not_active IP Right Cessation
-
2000
- 2000-01-31 HK HK00100582A patent/HK1021728A1/xx not_active IP Right Cessation
-
2002
- 2002-09-24 CY CY0200057A patent/CY2298B1/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA965190B (en) | Pharmaceutical composition. | |
| ZA9710071B (en) | Pharmaceutical composition. | |
| ZA9710927B (en) | Pharmaceutical composition. | |
| ZA9711508B (en) | Rapidly disintegrable pharmaceutical composition. | |
| ZA975533B (en) | Cyclosporin-containing pharmaceutical composition. | |
| ZA974735B (en) | Pharmaceutical compositions. | |
| HK1027957A1 (en) | Pharmaceutical composition. | |
| ZA977104B (en) | Pharmaceutical compositions. | |
| ZA9710272B (en) | Pharmaceutical compositions comprising diaryl-cyclomethylenpyrazole compounds. | |
| ZA989680B (en) | Pharmaceutical composition. | |
| ZA968081B (en) | Pharmaceutical composition. | |
| GB9610359D0 (en) | Pharmaceutical compositions | |
| ZA977327B (en) | Pharmaceutical composition containing 4-oxobutanoic acids. | |
| ZA987392B (en) | Pharmaceutical composition. | |
| ZA979726B (en) | Pharmaceutical compositions | |
| ZA972602B (en) | Pharmaceutical compositions. | |
| GB9613457D0 (en) | Pharmaceutical compositions | |
| GB9623962D0 (en) | Pharmaceutical composition | |
| GB9618376D0 (en) | Pharmaceutical compositions | |
| GB9610136D0 (en) | Pharmaceutical compositions | |
| HUP0003528A3 (en) | Pharmaceutical compositions containing dihydropolyprenols | |
| ZA966486B (en) | Pharmaceutical Composition. | |
| ZA979447B (en) | Pharmaceutical composition. | |
| ZA976028B (en) | Pharmaceutical compositions. | |
| ZA9710675B (en) | Pharmaceutical formulation. |